SuRo Capital Corp. filings document the regulatory record of a business development company and non-diversified closed-end management investment company. Form 8-K reports cover operating and financial results, preliminary estimates, net asset value, investment portfolio updates, material agreements, capital-structure disclosures and other material events tied to its common stock and notes.
Proxy statements describe shareholder voting matters, board elections, executive compensation advisory votes, auditor ratification and investment advisory agreement proposals. The filings also document portfolio valuation practices and governance arrangements for an internally managed BDC, including shareholder voting mechanics and capital-related disclosures.
SuRo Capital Corp. furnished preliminary third-quarter 2025 results, including an estimated net asset value between $9.00 and $9.50 per share as of September 30, 2025, compared with $9.18 per share at June 30, 2025 and $6.73 per share at September 30, 2024.
As of September 30, 2025, the company had 25,119,091 common shares outstanding and held positions in 37 portfolio companies. During the quarter, it invested $0.3 million in a Liquid Death convertible note and $5.0 million in HL Digital Assets preferred shares, while realizing net proceeds of $7.2 million and a $3.7 million gain from CW Opportunity 2 LP and $0.7 million in proceeds with a $0.5 million gain from GrabAGun Digital Holdings public warrants.
The company sold 1,230,984 shares via its at-the-market equity program for gross proceeds of about $10.8 million, with roughly $88.0 million of capacity remaining, and paid a $0.25 per share cash dividend on July 31, 2025.
Richard C. Szuch, a director of SuRo Capital Corp. (SSSS), reported acquiring 5,767 shares of the company's common stock on 09/03/2025 at a weighted-average price of $8.66 per share. The filing states the shares were purchased using a $50,000 cash grant approved by the board on July 30, 2025, intended to align his equity holding with other independent directors who received equity grants at the Annual Shareholder Meeting. The report was signed on 09/05/2025 and indicates direct ownership of 5,767 shares following the transactions.
Ronald Lott, a director of SuRo Capital Corp. (SSSS), reported a sale of common stock on 08/19/2025. He disposed of 7,500 shares at a weighted-average price of $8.81 per share, with individual trade prices ranging from $8.80 to $8.83. After the sale, Mr. Lott beneficially owned 29,623 shares, held directly. The filing also notes that the reported total includes restricted shares granted under the companys 2019 Equity Incentive Plan that vest in full on the earlier of May 28, 2026 or the companys next annual meeting closest to that anniversary. The Form 4 is signed by Mr. Lott on 08/22/2025 and indicates the transaction was reported by one reporting person.
SuRo Capital Corp. (SSSS) filed a Form 144 disclosing a proposed sale of 7,500 common shares through Goldman Sachs & Co. LLC on 08/19/2025. The aggregate market value of the shares at filing is $63,600 and the filing lists 23,888,107 shares outstanding. The shares were acquired on 05/31/2024 as restricted stock units issued as compensation by the issuer; payment is recorded as compensation. The filer reports no securities sold in the past three months and affirms they do not possess undisclosed material adverse information about the issuer. This notice serves as the required public disclosure of a planned insider sale under Rule 144.
On 08/11/2025 and 08/12/2025, Mark D. Klein, who serves as Chairman, Chief Executive Officer, President and a director of SuRo Capital Corp. (SSSS), reported purchases of the company's common stock. He acquired 4,571 shares on 08/11/2025 at a weighted-average price of $8.69 and 10,000 shares on 08/12/2025 at a weighted-average price of $8.45, for a total of 14,571 shares purchased.
Following these reported transactions his beneficial ownership increased to 1,530,590 shares. The filing's footnotes state this total includes 14,659 shares owned by Mr. Klein's spouse and restricted shares granted under the SuRo Capital Amended and Restated 2019 Equity Incentive Plan on Dec 15, 2023, Dec 10, 2024 and May 16, 2025. The Form 4 is signed and dated 08/12/2025.
What: SuRo Capital Corp. furnished a press release announcing its financial results for the fiscal quarter ended June 30, 2025, included as Exhibit 99.1 to this Current Report on Form 8-K dated August 6, 2025.
Filing specifics: The disclosure under Item 2.02 is expressly furnished, not filed for purposes of the Exchange Act and therefore is not automatically incorporated by reference into other registration statements. Item 9.01 lists Exhibit 99.1 (Press Release dated August 6, 2025) and Exhibit 104 (Cover Page Interactive Data File). The registrant is SuRo Capital Corp., incorporated in Maryland; securities registered include Common Stock (SSSS) and 6.00% Notes due 2026 (SSSSL) on the Nasdaq Global Select Market. This Form 8-K is signed by Allison Green, CFO and Corporate Secretary, dated August 6, 2025.
SuRo Capital Corp. (Nasdaq: SSSS) filed a Form 8-K on 8 July 2025 to furnish preliminary, unaudited figures for the quarter ended 30 June 2025.
Net asset value (NAV): management estimates NAV at $9.00 – $9.50 per share on 23,888,107 shares outstanding. This compares with $6.66 at 31 Mar 2025 and $6.94 at 30 Jun 2024, implying a quarter-over-quarter increase of roughly 35-43% and a year-over-year increase of 30-37%.
Portfolio composition: 36 positions (33 private, 3 public) at quarter-end.
- New investment: $5.0 million in Plaid Inc. Class A shares on 4 Apr 2025 via 1789 Capital Nirvana II LP; a 7% origination fee was paid.
- Realisations: Sold 222,240 CoreWeave shares for $25.3 million (realised gain $15.3 million) and 151,515 ServiceTitan shares for $15.9 million (gain $5.9 million). Entire directly held stakes in both companies were exited.
Capital return: the Board declared a $0.25 cash dividend on 3 Jul 2025, payable 31 Jul 2025 to holders of record 21 Jul 2025.
The figures are unaudited; actual results may differ when full Q2 results are released in August 2025. Forward-looking statements are subject to customary risks and uncertainties.